LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Roche Diagnostics and Protedyne Sign Global Agreement

By Biotechdaily staff writers
Posted on 12 Feb 2007
Roche Diagnostics (Indianapolis, In, USA) and Protedyne (Windsor, CT, USA), a company offering industrial robotic solutions, are bringing together their latest technologies for the benefit of scientists worldwide. In a collaborative effort, the two companies have integrated their technologies to provide a rapid and completely automated solution for high throughput quantitative polymerase chain reaction (PCR) applications.

Roche's LightCycler 480 instrument is a 96- or 384-well, plate-based quantitative PCR instrument. Combining speed with accuracy, the LightCycler 480 is a novel platform for gene-expression and mutation analysis. Based on innovative hardware and software, the LightCycler 480 instrument meets the needs of a broad range of genomic applications. The instrument builds upon the sensitivity and accuracy of the well-established LightCycler System, and now enables rapid high throughput quantitative PCR.

Protedyne's Radius is a new benchtop robotic system using the principles of industrial automation to offer high levels of flexibility, reproducibility, and process control for today's laboratories. Its radial design and vertical construction provide maximum functionality that can access areas of the bench top beyond its own footprint for simple and cost-effective device integration. The Radius system uses Protedyne's software that easily adapts to multiple protocols--and SmartTools, easily interchangeable tools with built-in microprocessors that store tool calibration information and track performance data.

Protedyne's Radius was a logical choice for the LightCycler 480 System as our technology provides the efficiency and throughput needed for highly- reproducible preparation across a broad range of scientific applications in genomics research, said Fran Tuttle, president and CEO of Protedyne. By combining the two systems, we can deliver to our customers exactly the throughput they are trying to achieve.



Related Links:
Roche Diagnostics
Protedyne

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Electrolyte Analyzer
BKE-B

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
12 Feb 2007  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
12 Feb 2007  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
12 Feb 2007  |   BioResearch